1. Home
  2. ALT vs LYTS Comparison

ALT vs LYTS Comparison

Compare ALT & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • LYTS
  • Stock Information
  • Founded
  • ALT 1997
  • LYTS 1976
  • Country
  • ALT United States
  • LYTS United States
  • Employees
  • ALT N/A
  • LYTS N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • LYTS Building Products
  • Sector
  • ALT Health Care
  • LYTS Consumer Discretionary
  • Exchange
  • ALT Nasdaq
  • LYTS Nasdaq
  • Market Cap
  • ALT 472.3M
  • LYTS 551.1M
  • IPO Year
  • ALT N/A
  • LYTS N/A
  • Fundamental
  • Price
  • ALT $5.28
  • LYTS $17.19
  • Analyst Decision
  • ALT Strong Buy
  • LYTS Strong Buy
  • Analyst Count
  • ALT 8
  • LYTS 2
  • Target Price
  • ALT $20.83
  • LYTS $28.00
  • AVG Volume (30 Days)
  • ALT 2.5M
  • LYTS 149.6K
  • Earning Date
  • ALT 05-08-2025
  • LYTS 04-24-2025
  • Dividend Yield
  • ALT N/A
  • LYTS 1.13%
  • EPS Growth
  • ALT N/A
  • LYTS N/A
  • EPS
  • ALT N/A
  • LYTS 0.76
  • Revenue
  • ALT $20,000.00
  • LYTS $523,020,999.00
  • Revenue This Year
  • ALT N/A
  • LYTS $20.24
  • Revenue Next Year
  • ALT N/A
  • LYTS $7.64
  • P/E Ratio
  • ALT N/A
  • LYTS $23.25
  • Revenue Growth
  • ALT N/A
  • LYTS 10.45
  • 52 Week Low
  • ALT $5.15
  • LYTS $13.63
  • 52 Week High
  • ALT $11.50
  • LYTS $25.50
  • Technical
  • Relative Strength Index (RSI)
  • ALT 38.48
  • LYTS 38.38
  • Support Level
  • ALT $5.15
  • LYTS $16.91
  • Resistance Level
  • ALT $6.09
  • LYTS $17.72
  • Average True Range (ATR)
  • ALT 0.42
  • LYTS 0.63
  • MACD
  • ALT -0.05
  • LYTS -0.11
  • Stochastic Oscillator
  • ALT 24.54
  • LYTS 24.28

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.

Share on Social Networks: